Barbara Laliotou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose: Current treatment of autoimmune endogenous posterior uveoretinitis (EPU) is limited by drug toxicity, unpredictable relapses on dose reduction and resistance to therapy. Administration of(More)
Nasal antigen administration successfully suppresses a model of organ-specific autoimmune disease, experimental autoimmune uveoretinitis (EAU), when administered prior to immunisation. We have(More)
  • 1